| |
|
|
|
GlobalCompliancePanel, Online Training Webinar
2011-02-15
Overview: The public media has been reporting the abuse of narcotic drugs prescribed for pain management with its focus on the legitimacy of prescriptions and the dispensing by a pharmacist. Both federal and state regulations have placed the responsibilities on the physician who wrote the prescription and the pharmacist who filled the prescription. Today's pharmacists will need to familiarize themselves with the stringent laws and regulations enforced by the Drug Enforcement Administration (DEA) through their Office of Diversion Control (Diversion). Since the focus of any DEA investigation is the legitimacy of a prescription, the initial target is the pharmacist who fulfilled the prescription. The pharmacy may be inspected in order to determine their handling of controlled substances purchased and dispensed as a prescription. The inspection targets record-keeping requirements, security of all controlled substances, and review of dispensed prescriptions.
Class participants will familiarize themselves with federal laws and DEA regulations requirements for handling of Schedules II though V controlled substances in a pharmacy setting and the record-keeping and security responsibilities placed on the pharmacist.
Areas Covered in the Session: - Discuss the types of federal criminal and civil actions that can be imposed on a pharmacy pertaining to the purchase, sale, transfer, dispensing, destruction and theft or loss of Schedules II through V controlled substances.
- Identify the responsibilities of DEA through their Diversion personnel to enforce federal laws and DEA regulations on the dispensing of controlled substances through a prescription.
- Discuss the steps that a pharmacy can use to determine the legitimacy of a prescription and when the pharmacist would need to discuss the necessity for the prescription and the individual treatment plan leading to the prescribing of a narcotic as part of the patient care.
- Discuss DEA record-keeping requirements pertaining to: Biennial Inventory; Executed or Voided DEA Form 222 and Invoices; Power of Attorney; Theft and Loss; Drug Destruction; and the Storage of Prescriptions.
- Identify DEA security requirements pertaining to: Alarm Systems; Pharmacy Security; Hiring of Employees; Proper Drug Disposal; Prevention of Thefts and Losses; and other security issues.
- Review DEA requirements pertaining to the filling of controlled substance prescriptions. This includes electronic prescriptions, a 90-day supply of a Schedule II drug, and prescriptions written for opioid dependency patients.
Who Will Benefit: Most participants of this presentation are pharmacists, pharmacy students, pharmacy owners, and regulatory personnel including members of a state Board of Pharmacy or Department of Health.
|
|
|
|
|
|
|
|
Organized by:
|
|
GlobalCompliancePanel |
|
|
Invited Speakers:
|
|
Carlos M. Aquino brings 36 years of experience of handling illicit and pharmaceutical controlled substances and regulated chemicals. His testimonial ability, both in federal and state courts, is proof of his investigative experience and skills. Carlos has 12 years of experience working for Philadelphia DEA Diversion Group, which is responsible for initiating prosecutions of those DEA registrants who violate the federal Controlled Substances Act or DEA regulations pertaining to handling these substances. This has included eight years as a Diversion Investigator and four years as a Group Supervisor. During his time at the DEA, he performed numerous regulatory inspections of manufacturers, distributors, importers/exporters, physicians, researchers, and pharmacies in order to determine their compliance with the federal laws and DEA regulations pertaining to controlled substances in Schedules II through V and regulated chemicals.
In addition to the above, Carlos has over 20 years of experience working for various law enforcement agencies including the Philadelphia Police. Carlos has a BA in Criminal Justice and has taught numerous courses during his time at the DEA.
He is skilled in interpreting the Controlled Substances Act (CSA) and the Code of Federal Regulations (CFR), assisting the pharmaceutical industry with compliance, and preparing and submitting Drug Enforcement Administration (DEA) Forms 41, 104, 106, 222, 236, 486.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2011-02-15
|
|
|
|
|
|
|
|
Registration:
|
|
Tuesday, February 15, 2011
10:00 AM PST | 01:00 PM EST | | | Live live online training only for one participant | | |
| | | | | | Corporate Live 4 to 10 participants from a single location (For multiple locations contact Customer Care) | | |
| | | Recorded Access recorded version only for one participant; unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar) | | |
|
|
|
E-mail:
|
|
webinars@globalcompliancepanel.com
|
|
|
|
|
|
|
|
|